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Introduction: The concentration of metabolites in different cerebral areas, so called neurochemical profile, can be taken as 
biomarker of regional development, differentiation or degeneration. The decline in memory and cognitive function is a normal 
consequence of aging and is accentuated by neurodegenerative pathologies, such as Alzheimer's disease, which cause progressive 
deterioration of learning and memory, attention and concentration, use of language, and other mental functions. These aging-
associated functional losses may be accompanied by neurochemical 
alterations that are unknown. The aim of this work was to evaluate 
the neurochemical alterations in the brain of aging mice. For that, 
high resolution in vivo 1H NMR spectroscopy was employed in a 
longitudinal way to determine the hippocampal content of 18 
metabolites composing the neurochemical profile.  
Methods: Localized 1H NMR spectroscopy was performed on 
a 14.1 T, 26 cm VNMRS spectrometer (Varian, Magnex) using a 
home-built 8 mm diameter quadrature surface coil (used both for RF 
excitation and signal reception) as previously described [1]. 
C57BL/6 mice were anaesthetized under 1 to 2% isoflurane in 
oxygen gas. Field homogeneity was adjusted by FASTMAP [2], and 
1H NMR spectra were acquired from VOIs placed in the 
hippocampus, using SPECIAL [3] with TE of 2.8 ms and TR of 4 s. 
Typically, spectra were acquired with 400 scans. Metabolite 
concentrations were estimated with LCModel [4]. The entire 
neurochemical profile was analyzed over the aging period with 
ANOVA with Bonferroni correction. In some cases, linear 
regression was used to describe the age-dependent observed 
modifications. 
Results: The neurochemical profile composed of 18 
metabolites was determined in vivo in the mouse hippocampus from 
young adulthood to 2 years old. Mice are being longitudinally 
scanned at 3 (n=18), 6 (n=18), 12 (n=10) and 24 (n=3) months of 
age. Although most metabolite concentrations were stable over time, 
some metabolites varied their content (figure 1). The total 
concentration of choline-containing compounds increased linearly 
age at a rate of 0.007 mmol/kg/month (R2=0.94, F=33.8, P<0.05). 
Glutamine concentrations increased at 2 years old compared to the 
other measured ages (+37±18%, P<0.05 analysis with ANOVA), 
while glutamate levels were largely unaltered (P>0.10). Taurine 
concentration increased at a rate of 0.048 mmol/kg/month (R2=0.97, 
F=71.4, P<0.05). These preliminary results also show that 
hippocampal levels of N-acetylaspartate (NAA) and glutamate were slightly reduced while total creatine tended to increase with age, 
although not statistically different (P>0.10 for all).  
Conclusion: The neurochemical profile of the mouse hippocampus has been determined longitudinally for 2 years of age. This is 
the first report of in vivo quantification of 18 metabolite concentrations in the brain of aging mice. These preliminary results suggest 
that glutamine, taurine and choline-containing compounds can be used as neurochemical markers of brain aging.  
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Figure 1. Metabolite concentrations in the mouse hippocampus
measured from 3 to 24 months of age. Data shown as
mean±SEM. Dashed lines represent significant linear
modification of metabolite levels with aging (P<0.05). For
glutamine, * P<0.05 compared with the other ages. 
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